Skip to main content
. 2021 Apr 4;11(4):270. doi: 10.3390/jpm11040270

Figure 3.

Figure 3

Example of a patient with neuroblastoma, showing diffuse pathological but faint osteomedullary uptake on planar [123I]mIBG scintigraphy (a), without increased uptake on [18F]FDG positron emission tomography (PET) maximum intensity projections (MIP) (b), but extensive pathological osteomedullary uptake on [68Ga]Ga-DOTATATE PET MIP (c). Note the different physiological distribution between tracers.